Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by Brokerages

Summary by MarketBeat
Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) have received an average recommendation of "Buy" from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has issued

1 Articles

MarketBeatMarketBeat
Center

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) Given Average Recommendation of "Buy" by Brokerages

Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) have received an average recommendation of "Buy" from the eight research firms that are presently covering the firm, MarketBeat Ratings reports. Seven analysts have rated the stock with a buy recommendation and one has issued

·Sioux Falls, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Tuesday, September 1, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Bridgewater, New Jersey icon

Bridgewater, New Jersey

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal